FIP1L1-PDGFRA Detection Kit
£735.00
The geneMAP™ FIP1L1-PDGFRA Detection Kit is intended for detection and quantitation of FIP1L1 exon 9/PDGFRA exon 12, FIP1L1 exon 10/PDGFRA exon 12, FIP1L1 exon11/PDGFRA exon 12, FIPL1 exon 12/PDGFRA exon 12 & FIPL1 exon 13/PDGFRA exon 12 fusion transcripts in bone marrow or peripheral blood samples of patients who have been diagnosed with idiopathic hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders. The results obtained are intended to be used as an aid to monitor efficacy of treatment in patients undergoing therapy, and for minimal residual disease (MRD) follow-up to monitor disease relapse.
- Superior Analytical Sensitivity: Achieves a log4 reduction in detection sensitivity, enabling the identification of low levels of the FIP1L1-PDGFRA fusion transcript.
- One-Step RT-qPCR Technology: Streamlines the testing process, making it both quick and straightforward to execute.
- Multiplex PCR: Facilitates accurate relative quantitation by comparing fusion transcripts against ABL1 gene expression, enhancing diagnostic precision.
- Instrument Compatibility: Designed for use with FAM and VIC/HEX dual-color real-time PCR instruments, ensuring versatility across laboratory settings.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring the kit’s reliability and quality.
- Leukemia Diagnosis and Monitoring: Specifically targets the FIP1L1-PDGFRA fusion gene for patients suspected of or diagnosed with chronic eosinophilic leukemia or a subset of acute myeloid leukemia (AML), playing a key role in diagnosis, prognosis, and treatment monitoring strategies.
- Technology: Utilizes one-step RT-qPCR with multiplex PCR for the detection and relative quantitation of the FIP1L1-PDGFRA fusion transcript.
- Sensitivity: Features superior analytical sensitivity (log4 reduction) for detecting low levels of the target gene.
- Compatibility: Compatible with FAM and VIC/HEX dual-color real-time PCR instruments.
- Certification: Carries the CE-IVD mark, indicating compliance with EU regulations for in vitro diagnostic use.
- Superior Analytical Sensitivity: Achieves a log4 reduction in detection sensitivity, enabling the identification of low levels of the FIP1L1-PDGFRA fusion transcript.
- One-Step RT-qPCR Technology: Streamlines the testing process, making it both quick and straightforward to execute.
- Multiplex PCR: Facilitates accurate relative quantitation by comparing fusion transcripts against ABL1 gene expression, enhancing diagnostic precision.
- Instrument Compatibility: Designed for use with FAM and VIC/HEX dual-color real-time PCR instruments, ensuring versatility across laboratory settings.
- CE-IVD Certification: Meets European standards for in vitro diagnostic medical devices, ensuring the kit’s reliability and quality.
- Leukemia Diagnosis and Monitoring: Specifically targets the FIP1L1-PDGFRA fusion gene for patients suspected of or diagnosed with chronic eosinophilic leukemia or a subset of acute myeloid leukemia (AML), playing a key role in diagnosis, prognosis, and treatment monitoring strategies.
- Technology: Utilizes one-step RT-qPCR with multiplex PCR for the detection and relative quantitation of the FIP1L1-PDGFRA fusion transcript.
- Sensitivity: Features superior analytical sensitivity (log4 reduction) for detecting low levels of the target gene.
- Compatibility: Compatible with FAM and VIC/HEX dual-color real-time PCR instruments.
- Certification: Carries the CE-IVD mark, indicating compliance with EU regulations for in vitro diagnostic use.
Why Choose Clent
We strive to enable our customers to focus on the results of their work, rather than the tools they use. Need to speak with a member of our team? Get in touch today.
